Workflow
CIRC(01763)
icon
Search documents
中国同辐(01763) - 截至二零二五年七月三十一日止月份之股份发行人的证券变动月报表
2025-08-01 08:34
FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 中國同輻股份有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01763 | 說明 | H股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 79,968,800 | RMB | | | 1 RMB | | 79,968,800 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 79,968,800 | RMB | | | 1 RMB | | 79,968,800 | | 2. 股份分類 | ...
中国同辐(01763.HK):中核高通拟透过公开挂牌方式进行潜在增资
Ge Long Hui· 2025-07-31 12:45
Core Viewpoint - China Nuclear High-Tech (01763.HK) announced plans for capital increase through Beijing Property Exchange to address funding needs and optimize capital structure [1] Group 1: Company Financials - As of December 31, 2024, China Nuclear High-Tech's subsidiary, Chengdu Zhongke Gaotong Isotope Co., has a debt-to-asset ratio of 68.41% [1] - The capital increase aims to alleviate financial pressure and support core business expansion and operational capacity enhancement [1] Group 2: Strategic Implications - The board believes that the capital increase will ensure sustainable development for China Nuclear High-Tech and align with overall financial management requirements [1] - This move is expected to enhance the overall asset quality and risk resistance capability of the group [1]
中国同辐:中核高通拟透过公开褂牌程序进行增资
Zhi Tong Cai Jing· 2025-07-31 12:43
中国同辐(01763)公布,公司非全资附属公司成都中核高通同位素股份有限公司(中核高通)拟透过于北京 产权交易所公开褂牌程序进行增资。 截至2024年12月31日,中核高通资产负债率为68.41%,为解决发展资金需求及优化其资本结构,中核 高通拟透过潜在增资事项缓解其资金压力,支持其核心业务拓展及运营能力提升。董事会认为,此次增 资既能保障中核高通的可持续发展,亦符合集团整体财务管控要求,有利于增强集团整体资产品质和抗 风险能力。 ...
中国同辐(01763):中核高通拟透过公开褂牌程序进行增资
智通财经网· 2025-07-31 12:40
截至2024年12月31日,中核高通资产负债率为68.41%,为解决发展资金需求及优化其资本结构,中核 高通拟透过潜在增资事项缓解其资金压力,支持其核心业务拓展及运营能力提升。董事会认为,此次增 资既能保障中核高通的可持续发展,亦符合集团整体财务管控要求,有利于增强集团整体资产品质和抗 风险能力。 智通财经APP讯,中国同辐(01763)公布,公司非全资附属公司成都中核高通同位素股份有限公司(中核 高通)拟透过于北京产权交易所公开褂牌程序进行增资。 ...
中国同辐(01763) - 内幕消息 - 中核高通透过公开掛牌方式进行潜在增资事项
2025-07-31 12:34
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 CHINA ISOTOPE & RADIATION CORPORATION 中國同輻股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:1763) 內幕消息 中核高通透過公開掛牌方式進行潛在增資事項 潛在增資事項的對價將基於一名有信譽的估值師對中核高通進行的評估值釐定。 進行潛在增資事項的理由及裨益 截至2024年12月31日,中核高通資產負債率為68.41%,為解決發展資金需求及優 化其資本結構,中核高通擬透過潛在增資事項緩解其資金壓力,支持其核心業務 拓展及運營能力提升。董事會認為,此次增資既能保障中核高通的可持續發展, 亦符合本集團整體財務管控要求,有利於增強本集團整體資產品質和抗風險能力。 1 有關中核高通的資料 中核高通為本公司的非全資附屬公司,主要從事放射性同位素產品的開發、生產 和銷售,兼營進出口貿易、貨物運輸。截至本公告日期,本公司、四川青衣開發 投資集團有限公司、瑪西 ...
瑞银增持中国同辐3.42万股 每股作价约15.98港元
Zhi Tong Cai Jing· 2025-07-30 11:16
香港联交所最新资料显示,7月24日,瑞银增持中国同辐(01763)3.42万股,每股作价15.9819港元,总金 额约为54.66万港元。增持后最新持股数目约为403.05万股,最新持股比例为5.04%。 ...
瑞银增持中国同辐(01763)3.42万股 每股作价约15.98港元
智通财经网· 2025-07-30 11:12
智通财经APP获悉,香港联交所最新资料显示,7月24日,瑞银增持中国同辐(01763)3.42万股,每股作 价15.9819港元,总金额约为54.66万港元。增持后最新持股数目约为403.05万股,最新持股比例为 5.04%。 ...
港股公告掘金 | 名创优品:公司正在对其以“TOP TOY”品牌运营的潮流玩具业务潜在分拆上市可能性进行初步评估
Zhi Tong Cai Jing· 2025-06-08 12:40
Major Events - JiuTai Rural Commercial Bank (06122) plans to sell 78.51% stake in HuanShan HuiMin Village Bank for 40.4 million yuan [1] - Vanke Enterprises (02202) intends to receive a loan of up to 3 billion yuan from its major shareholder, Shenzhen Metro Group [1] - China Gas Holdings (08246) signed a memorandum of understanding with the Lao Ministry of Industry and Commerce to explore cooperation in developing fuel and natural gas supply networks in Laos [1] - Miniso Group (09896) is conducting a preliminary assessment on the potential spin-off listing of its trendy toy business operated under the "TOP TOY" brand [1] - Baiyunshan Pharmaceutical (00874) subsidiary received approval from the National Medical Products Administration for the drug registration certificate of Tadalafil tablets (2.5mg, 5mg) [1] - Huaxing Capital Holdings (01911) portfolio company Circle successfully listed on the New York Stock Exchange, marking the first IPO milestone in the global stablecoin sector [1] - China National Nuclear Corporation (01763) plans to initiate its first irradiation station cooperation project in Peru [1] Operating Performance - Yuexiu Property (00123) reported a cumulative contract sales amount of approximately 50.7 billion yuan in the first five months, an increase of about 26.5% year-on-year [1] - China Overseas Land & Investment (00688) recorded a cumulative property sales amount of approximately 90.4 billion yuan in the first five months, a decrease of 11.1% year-on-year [1] - Shimao Group (00813) reported a cumulative contract sales total of 11.2 billion yuan in the first five months, a decrease of 18.71% year-on-year [1] - Zhongliang Holdings (02772) achieved a cumulative contract sales amount of approximately 5.37 billion yuan in the first five months, a decrease of 33.38% year-on-year [1] - GAC Group (02238) experienced a year-on-year decline in May's automobile production by 8.16% and a sales drop of 24.80% [1] - Poly Property Group (00119) achieved a contract sales amount of approximately 21.8 billion yuan in the first five months, an increase of 3.81% year-on-year [1] - New天绿色能源 (00956) completed a power generation volume of approximately 7.29 million megawatt-hours in the first five months, an increase of 10.86% year-on-year [1]
央企控股上市公司密集发声,多措并举加强市值管理
Di Yi Cai Jing· 2025-06-08 02:45
Core Viewpoint - The management of state-owned enterprises (SOEs) in China has shifted from policy advocacy to substantive implementation, with expectations for valuation restructuring and market confidence enhancement as assessment mechanisms and supporting policies improve [1][5]. Group 1: SOE Value Management - The State-owned Assets Supervision and Administration Commission (SASAC) has emphasized improving the quality of SOEs' listed companies and enhancing value management to stabilize market expectations [1][4]. - Several SOEs have held performance briefings and investor engagement activities, committing to increase dividend payouts and enhance shareholder returns while focusing on core business improvement and innovation [1][2]. - China National Nuclear Corporation (CNNC) reported a market value of approximately 260 billion yuan, with a year-on-year increase of over 30%, highlighting its commitment to shareholder value through strategic investments [1][2]. Group 2: Dividend Policies - China National Power has maintained a cash dividend payout ratio exceeding 35% for ten consecutive years, with the 2024 dividend ratio reaching a historical high of 41.92%, totaling over 24 billion yuan in cumulative dividends [2]. - China Nuclear Technology has consistently returned cash dividends for 18 years, with a 2024 payout ratio of 32.43% and an average payout ratio exceeding 30% from 2020 to 2024 [2]. - China Huaneng Group is focused on enhancing dividend frequency and amounts across its listed companies to stabilize market value [2]. Group 3: Innovation and Reform - Accelerating innovation and deepening reforms are crucial for SOEs to enhance value management and improve the quality of listed companies [3][4]. - The State Grid Corporation is implementing multiple measures to promote high-quality development of its listed companies, focusing on energy transition and new power system construction [3]. - China Aerospace Science and Technology Corporation aims to enhance innovation capabilities and integrate technology and industry innovation to improve value creation [3]. Group 4: Regulatory Framework - The SASAC has issued guidelines to improve the market value management of SOEs, emphasizing the importance of maintaining investor rights and promoting healthy capital market development [3][4]. - Recent analyses indicate that value management is essential for listed companies to enhance intrinsic value and market performance through various compliant methods [4][5]. - SOEs are increasingly formalizing their value management practices, including the establishment of value enhancement plans and regular communication with investors [5].
中核集团旗下上市公司2024年市值合计约2600亿元
Xin Hua Cai Jing· 2025-06-06 12:21
Group 1 - The core viewpoint is that China National Nuclear Corporation (CNNC) expects a market capitalization of approximately 260 billion yuan for its listed companies in 2024, with an annual growth rate exceeding 30% [1] - CNNC emphasizes the importance of market value performance for its listed companies, with several achieving an A-grade in information disclosure assessments from stock exchanges in 2024 [1] - China Nuclear Power successfully completed a 14 billion yuan refinancing project for A-shares in 2024 [1] Group 2 - China Nuclear Construction is enhancing its nuclear power construction capabilities and actively expanding into international markets, achieving significant milestones in the International Thermonuclear Experimental Reactor (ITER) project [1] - Tongfang Co. is focusing on strategic leadership and innovation, resulting in significant market development achievements and continuous growth in overseas revenue [1] - China Isotope & Radiation is deepening its "6+N" industry layout strategy, forming a collaborative ecosystem in core businesses such as nuclear medicine and irradiation technology applications [1] Group 3 - CNNC's overall performance is steadily improving, having received an A-grade in annual performance assessments from the State-owned Assets Supervision and Administration Commission for 19 consecutive years [2] - The year 2025 marks the 70th anniversary of China's nuclear industry and is designated as CNNC's "Pursuit of Excellence Year," aiming to support high-quality development of its listed companies through excellent operational performance and management efficiency [2] - CNNC plans to leverage capital market functions to assist in industrial transformation and upgrading, promoting high-level circulation of technology, industry, and finance [2]